Tag: SPLK

PBIO Report, Options Ideas

Pressure BioSciences, Inc. (OTCMKTS:PBIO)

Pressure BioSciences is a company we’ve had on our watchlist for quite some time, with our first mention of the stock coming in the summer of 2019. We’re taking a renewed look at it now for a number of reasons, not least of which being the long term pattern of the chart.

If you glance at the three-year snapshot below (via OTCMARKETS.COM), a clear pattern can be easily spotted. The stock has an undeniable recorded history of consolidating in the winter months,only to spring back with vigor in the early portions of each New Year.

On its own, that interesting technical tendency would be enough to catch our attention, but Pressure BioSciences also seems to be planning for a big year of developments in 2021 as mentioned in the company’s Q3 Business Update released just a couple of weeks ago. According to the company, it expects the upcoming release of its Ultra Shear Technology™ in mid-2021 to drive notable growth and progress toward becoming profitable.

That only scratches the surface of PBIO’s products, projects and partnerships, which were expounded upon in the aforementioned Quarterly Update (>>View Now on OTCMARKETS.COM) Stay tuned for any further updates which we’ll be sure to pass along as expediently as possible!
_____

We also suggest our readers take a moment to view a real-time look at the short term PBIO chart . The stock is coming off of support at the 50DMA of 1,60, and it breached the 200DMA yesterday, closing just below it. If PBIO can break the 200DMA at 2.08 and hold above, our next key resistance points come at 2.50, 3.00, and 4.00-4.50. 


View PBIO Video Chart
______

For All Investor Inquiries on PBIO,Contact:
Gary Zwetchkenbaum, Plum Tree Consulting LLC
Email: gzplumtree@gmail.com
Phone: (516) 455-7662
Web: plumtreeconsultingllc.com 

SPDR S&P500 (ETF) SPY – Options Review

We also wanted to quickly highlight the SPY 12/02 $365-366 Calls which we signaled for a last minute idea in yesterday morning’s premarket report. We saw some pretty good intraday gains out of those targets.

SPY 12/02 $365-366 Calls
$365: .59-2.19 (+271%)
$366: .28-1.32 (+371%)
_____

Fresh Options Ideas:
SPLK Weekly $170-160 Puts
CRWD Weekly $155-162.50 Calls
SIG Weekly $30.50-32 Calls 

Sweeping Options Success

Total Options Success 

We have a multitude of options updates for our readers this morning, including new highs for our Campbell’s ideas from Wednesday morning, and the figures from all three of yesterday morning’s fresh options ideas, which all worked out extremely well.

It is a continuation of what has been an incredibly adept playing of the current market conditions. Our readers are welcome to check our record thoughout this time, and any other (Find ALL of our reports  easily at BlueHorseshoeStocks.com)

CPB Weekly $49-50.50 Calls
$49: 2.03-4.45 (+119%)
$50: 1.25-3.82 (+206%)
$50.50: .98-2.80 (+186%)
_____

VIPS Weekly $13.50-14.50 Calls
$13.50: 1.25-2.79 (+123%)
$14: .85-2.90 (+241%)
$14.50: .40-1.95 (+388%)
_____

MRVL Weekly $23.50-25 Calls
$23.50: 1.10-2.21 (+101%)
$24: .45-1.78 (+296%)
$24.50: .42-1.32 (+214%)
**$25: .01-.95 (+9400%)**
_____

SPLK Weekly $152.50-149 Puts
$152.50: 5.15-12.80 (+149%)
$150: 3.58-11.00 (+207%)
$149: 3.10-8.79 (+185%)
_____

Fresh Ideas:
SPY Weekly $294-295.50 Calls*

*Don’t trade weekly options on a Friday unless you are an advanced level trader with access to disposable funds!


Hear AtLast Holdings, Inc. HRAL

We’ve been tagging a lot of OTC stocks for observation in our extended watchlists, as penny plays can often see a rise in activity when uncertainty hits the major markets.

HRAL was the most impressive performer from yesterday’s list, with two distinctive moves on the day, first from .035-.0549 (+57%) and then from .0301-.043 (+43%) works out to cumulative gains of up to 100%

More Pharma Winners

Pharma Updates

Ocular Therapeutics, Inc. OCUL  – We’ve been observing OCUL for a couple months now, beginning with our report from Dec. 30th. The stock did rise considerably in a predictable pattern over the first two months of 2020, and thanks largely in part to the effect the coronavirus is having on many pharma plays, the stock really kicked the increases into high gear this week.

Subsequent to our report just prior to the New Year, OCUL was trading for a little as 3.83 a share, and its new high yesterday came in at 7.48, marking a solid rise of 95%
_____

Inovio Pharmaceuticals, Inc. INO  – We signaled INO on Thursday morning, and provided an update again in yesterday’s report. From its low of 3.83, we have now witnessed an upswing of 145% as of the stock’s new high of 9.40 achieved yesterday.

The markets have begun to swing back and forth with just the kind of volatility that we relish, but it is highly unlikely that we are seeing the last of the coronavirus’ effect on stocks in general. With the outbreak not yet contained, it stands to reason that this volatility will persist for the foreseeable future.

Campbell Soup Co. CPB – Options Update 

We offered up an options idea for the Campbell’s chain yesterday, the CPB Weekly $49-50.50 Calls. While the 49.50’s didn’t trade substantial volume, the other three contract sets in the range saw some nice moves.

CPB Weekly $49-50.50 Calls
$49: 2.03-3.10 (+53%)
$50: 1.25-2.58 (+106%)
$50.50: .98-2.10 (+114%)

Fresh Options Ideas:
VIPS Weekly $13.50-14.50 Calls
MRVL Weekly $23.50-25 Calls
SPLK Weekly $152.50-149 Puts 

Extended Watchlist:
HRAL, ARYC, SPOM, NVNT, IQST, ABML